Buscar
Mostrando ítems 1-10 de 7168
Topical pain management with the 5 lidocaine medicated plaster a review
(2012)
Background: The topical 5 lidocaine medicated plaster is recommended as first-line treatment for localized peripheral neuropathic pain. Scope: In order to provide an overview of the efficacy and safety of the lidocaine ...
Development of Topical Miltefosine formulations for the treatment of Cutaneous Leishmaniasis
(Editora Cientifica Digital, 2021)
Cutaneous leishmaniasis (CL) is a neglected tropical disease endemic in ~90 countries, with an increasing incidence. Presently available pharmacotherapy implies the systemic administration of moderately/very toxic drugs. ...
To circ or not to circ: clinical and pharmacoeconomic outcomes of a prospective trial of topical steroid versus primary circumcision
(Sociedade Brasileira de Urologia, 2010-02-01)
PURPOSE: To compare the efficacy and costs of circumcision versus topical treatment using a prospective pharmacoeconomic protocol. MATERIALS AND METHODS: We treated 59 patients (3-10 years of age) randomized into two groups: ...
Capsaicin topical cream (8%) for the treatment of myofascial pain syndrome
(Sociedade Brasileira de Anestesiologia, 2019-12-20)
Reduction in the inflammatory markers CD4, IL-1, IL-6 and TNFα in dogs with keratoconjunctivitis sicca treated topically with mesenchymal stem cells
(2019-08-01)
Keratoconjunctivitis sicca (KCS) is of predominantly immune-mediated origin. Dogs are an excellent model for understanding this disease, as the origin of KCS in dogs is like that in humans. The objective of this study was ...
DETC-based bacterial cellulose bio-curatives for topical treatment of cutaneous leishmaniasis
(Nature Publishing Group, 2016-12-06)
The treatment of leishmaniasis still relies on drugs with potentially serious adverse effects. Herein, we tested a topical formulation of bacterial cellulose (BC) membranes containing Diethyldithiocarbamate (DETC), a ...
Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis
(Springer, 2021-01-27)
Cutaneous leishmaniasis (CL) is a neglected tropical disease endemic in ~ 90 countries, with an increasing incidence. Presently available pharmacotherapy implies the systemic administration of moderately/very toxic drugs. ...